TY - JOUR
T1 - Significance of mesenteric lymphadenopathy after pancreaticoduodenectomy for periampullary carcinomas
T2 - Evaluation with serial MDCT studies
AU - Ishigami, Kousei
AU - Yoshimitsu, Kengo
AU - Irie, Hiroyuki
AU - Tajima, Tsuyoshi
AU - Asayama, Yoshiki
AU - Hirakawa, Masakazu
AU - Kakihara, Daisuke
AU - Shioyama, Yoshiyuki
AU - Nishihara, Yunosuke
AU - Yamaguchi, Koji
AU - Honda, Hiroshi
N1 - Copyright:
Copyright 2008 Elsevier B.V., All rights reserved.
PY - 2007/3
Y1 - 2007/3
N2 - Objective: To evaluate the significance of mesenteric lymphadenopathy arising after pancreaticoduodenectomy (PD) for periampullary carcinomas. Materials and methods: Serial multidetector CT (MDCT) studies in 44 patients after PD for periampullary carcinomas (Group A) were retrospectively reviewed, the incidence and interval changes of mesenteric lymphadenopathy were evaluated, and comparisons were made with 21 patients who underwent PD for benign diseases (Group B). Results: In Group A, mesenteric lymphadenopathy was seen in 31 of 44 (70.5%) patients. The short axis diameter of the largest lymph node ranged from 6.2 to 11.5 mm (mean ± S.D.: 8.6 ± 1.4 mm), and the short-axis-to-long-axis (S/L) ratio ranged from 0.46 to 0.99 (mean ± S.D.: 0.69 ± 0.12). Six of the 31 (19.4%) mesenteric lymphadenopathy cases showed interval increases in size on follow-up studies, and three cases showed new development of mesenteric lymphadenopathy: all of these nine cases had concurrent recurrence in the mesenteric root. In Group B, 11 (52.4%) had mesenteric lymphadenopathy. The short axis diameter of the largest lymph node ranged from 5.6 to 10.9 mm (mean ± S.D.: 8.0 ± 1.9 mm) and the S/L ratio ranged from 0.48 to 0.93 (mean ± S.D.: 0.67 ± 0.12). Differences in the incidence, short axis diameter and S/L ratio were not significant between Groups A and B (p = 0.154, 0.271 and 0.654, respectively). Conclusion: Mesenetric lymphadenopathy after PD less likely reflects recurrence. Lymph node metastasis may be suggested only when coexisting recurrent mass is found in the proximal mesenteric root.
AB - Objective: To evaluate the significance of mesenteric lymphadenopathy arising after pancreaticoduodenectomy (PD) for periampullary carcinomas. Materials and methods: Serial multidetector CT (MDCT) studies in 44 patients after PD for periampullary carcinomas (Group A) were retrospectively reviewed, the incidence and interval changes of mesenteric lymphadenopathy were evaluated, and comparisons were made with 21 patients who underwent PD for benign diseases (Group B). Results: In Group A, mesenteric lymphadenopathy was seen in 31 of 44 (70.5%) patients. The short axis diameter of the largest lymph node ranged from 6.2 to 11.5 mm (mean ± S.D.: 8.6 ± 1.4 mm), and the short-axis-to-long-axis (S/L) ratio ranged from 0.46 to 0.99 (mean ± S.D.: 0.69 ± 0.12). Six of the 31 (19.4%) mesenteric lymphadenopathy cases showed interval increases in size on follow-up studies, and three cases showed new development of mesenteric lymphadenopathy: all of these nine cases had concurrent recurrence in the mesenteric root. In Group B, 11 (52.4%) had mesenteric lymphadenopathy. The short axis diameter of the largest lymph node ranged from 5.6 to 10.9 mm (mean ± S.D.: 8.0 ± 1.9 mm) and the S/L ratio ranged from 0.48 to 0.93 (mean ± S.D.: 0.67 ± 0.12). Differences in the incidence, short axis diameter and S/L ratio were not significant between Groups A and B (p = 0.154, 0.271 and 0.654, respectively). Conclusion: Mesenetric lymphadenopathy after PD less likely reflects recurrence. Lymph node metastasis may be suggested only when coexisting recurrent mass is found in the proximal mesenteric root.
UR - http://www.scopus.com/inward/record.url?scp=33847234638&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=33847234638&partnerID=8YFLogxK
U2 - 10.1016/j.ejrad.2006.10.008
DO - 10.1016/j.ejrad.2006.10.008
M3 - Article
C2 - 17112696
AN - SCOPUS:33847234638
VL - 61
SP - 491
EP - 498
JO - European Journal of Radiology
JF - European Journal of Radiology
SN - 0720-048X
IS - 3
ER -